Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction

被引:26
作者
Xu, Jianrong [2 ]
Xu, Jun [1 ]
Chen, Hongzhuan [2 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou 510006, Guangdong, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, Shanghai 200025, Peoples R China
关键词
muscarinic toxin; muscarinic acetylcholine receptor; molecular dynamics simulations; protein-protein docking; MOLECULAR-DYNAMICS SIMULATIONS; FAST INTERACTION REFINEMENT; COUPLED RECEPTOR; ALLOSTERIC SITE; AMINO-ACID; STRUCTURE VALIDATION; CRYSTAL-STRUCTURE; BINDING-SITE; SNAKE TOXINS; SUBTYPES;
D O I
10.1080/07391102.2012.674188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MT7 is a selective human muscarinic acetylcholine receptor 1 (hM1) allosteric binder with subnanomolar affinity. Understanding the binding mode of hM1-MT7 will give insights to discover small molecular ligand for hM1. MT7 is a peptide, and hM1 is a G-protein-coupled membrane receptor. Therefore, we have employed homology modeling, protein-protein docking, explicit membrane molecular dynamics (MD) simulations, and molecular mechanic/Poisson-Boltzmann surface area energy decomposition analysis approaches to reveal the hM1-MT7 binding mode. The binding mode is consistent with the experimental data. We have discovered that the binding mode consists of three interaction regions in five residue interaction clusters. By analyzing the cluster representative structures, the cluster residues form an interaction network, which shows a multiple-point-to-site binding mode. Hydrogen binding statistical analysis reveals that E170 (hM1) and R34 (MT7) are both locked in electrostatic cages with counter charges, respectively. This is confirmed by the dynamic distances calculation between these residues, and biological mutant experiments.
引用
收藏
页码:30 / 44
页数:15
相关论文
共 69 条
  • [61] LIGPLOT - A PROGRAM TO GENERATE SCHEMATIC DIAGRAMS OF PROTEIN LIGAND INTERACTIONS
    WALLACE, AC
    LASKOWSKI, RA
    THORNTON, JM
    [J]. PROTEIN ENGINEERING, 1995, 8 (02): : 127 - 134
  • [62] Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI [10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO
  • [63] 2-F, 10.1021/jp801245h]
  • [64] Development and testing of a general amber force field
    Wang, JM
    Wolf, RM
    Caldwell, JW
    Kollman, PA
    Case, DA
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (09) : 1157 - 1174
  • [65] Automatic atom type and bond type perception in molecular mechanical calculations
    Wang, Junmei
    Wang, Wei
    Kollman, Peter A.
    Case, David A.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2006, 25 (02) : 247 - 260
  • [66] Structure of a β1-adrenergic G-protein-coupled receptor
    Warne, Tony
    Serrano-Vega, Maria J.
    Baker, Jillian G.
    Moukhametzianov, Rouslan
    Edwards, Patricia C.
    Henderson, Richard
    Leslie, Andrew G. W.
    Tate, Christopher G.
    Schertler, Gebhard F. X.
    [J]. NATURE, 2008, 454 (7203) : 486 - 491
  • [67] The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
    Warne, Tony
    Moukhametzianov, Rouslan
    Baker, Jillian G.
    Nehme, Rony
    Edwards, Patricia C.
    Leslie, Andrew G. W.
    Schertler, Gebhard F. X.
    Tate, Christopher G.
    [J]. NATURE, 2011, 469 (7329) : 241 - 244
  • [68] Novel insights into muscarinic acetylcholine receptor function using gene targeting technology
    Wess, J
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (08) : 414 - 420
  • [69] Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms
    Yeagle, PL
    Choi, G
    Albert, AD
    [J]. BIOCHEMISTRY, 2001, 40 (39) : 11932 - 11937